Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial.
暂无分享,去创建一个
J. S. San Martin | M. Whyte | T. Carpenter | G. Gottesman | E. Imel | M. Mao | A. Skrinar
暂无分享,去创建一个
J. S. San Martin | M. Whyte | T. Carpenter | G. Gottesman | E. Imel | M. Mao | A. Skrinar